Nectar Phytochems Profile
Key Indicators
- Authorised Capital ₹ 7.10 M
as on 16-06-2024
- Paid Up Capital ₹ 7.10 M
as on 16-06-2024
- Company Age 9 Year, 22 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.78 Cr
as on 16-06-2024
- Satisfied Charges ₹ 1.66 Cr
as on 16-06-2024
- Revenue -10.03%
(FY 2023)
- Profit -3.50%
(FY 2023)
- Ebitda 49.44%
(FY 2023)
- Net Worth 37.78%
(FY 2023)
- Total Assets 15.89%
(FY 2023)
About Nectar Phytochems
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.10 M and a paid-up capital of Rs 7.10 M.
The company currently has active open charges totaling ₹7.78 Cr. The company has closed loans amounting to ₹1.66 Cr, as per Ministry of Corporate Affairs (MCA) records.
Subhash Naithani and Meenakshi Naithani serve as directors at the Company.
- CIN/LLPIN
U36912UP2015PTC074748
- Company No.
074748
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Dec 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Noida, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nectar Phytochems Private Limited offer?
Nectar Phytochems Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Extracts, Herbal Extracts, Ayurvedic Powder and Medicinal Herbs, Ayurvedic & Herbal Powder, Animal Medicines & Health Care, Veterinary Medicines, Flavours & Aromatics, Food Additive.
Who are the key members and board of directors at Nectar Phytochems?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhash Naithani  | Director | 01-Dec-2015 | Current |
| Meenakshi Naithani | Director | 01-Dec-2015 | Current |
Financial Performance of Nectar Phytochems.
Nectar Phytochems Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 10.03% decrease. The company also saw a slight decrease in profitability, with a 3.5% decrease in profit. The company's net worth Soared by an impressive increase of 37.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nectar Phytochems?
In 2023, Nectar Phytochems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 18 Jan 2024 | ₹2.97 Cr | Open |
Hdfc Bank Limited Creation Date: 18 Apr 2023 | ₹7.00 M | Open |
Hdfc Bank Limited Creation Date: 29 Mar 2023 | ₹1.45 Cr | Open |
How Many Employees Work at Nectar Phytochems?
Unlock and access historical data on people associated with Nectar Phytochems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nectar Phytochems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nectar Phytochems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
